New head of Trajan Accelerator to drive longterm growth with start-ups

New head of Trajan Accelerator to drive longterm growth with start-ups

March 21, 2016

Trajan Scientific and Medical (Trajan) is pleased to announce the appointment of Elpis Barons as General Manager of the Trajan Accelerator. 

Conceived in late 2015, Trajan Accelerator provides a collaborative model targeting early stage enterprises sharing Trajan’s vision to positively impact human wellbeing through the application of science into society.

Ms Barons joins Trajan with extensive international business experience having nurtured her own business, Barons Medical Consulting since 2008 assisting international device manufactures and medical technology organizations through human clinical trials for the Australian market through strategic planning, sponsorship, clinical support and monitoring of the human clinical trials.

Her previous position in the UK with MedNova Ltd (acquired by Abbott Vascular) as the International Director of Sales and Marketing of emerging technologies for cardiovascular intervention, shows demonstrated success in the development and execution of human clinical trials, sales distribution and marketing.

Ms Baron’s passion for seeing the success of start-ups, combined with her knowledge of the clinical market and business acumen will ensure the Trajan Accelerator drives success and ensures we have a long and meaningful impact on human wellbeing across the globe.

The Trajan Accelerator model focuses on medtech companies with technologies, capabilities or markets that will contribute to improved wellbeing. Through financial and in kind support to facilitate growth, the Accelerator Company, and its staff then become part of the Trajan Group, while retaining a majority share and its identify.  Through accessing Trajan’s Corporate Services, the Accelerator Company is able to focus on their passion, while Trajan facilitates growth and whole business support through marketing, compliance, HR and global supply chain expertise etc.

Trajan’s active investment in the Accelerator program aims to help the start-up cross the “Valley of Death” and together build longterm sustainable businesses.


Photo (L-R): Elpis Barons, General Manager, Accelerator Group, Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical.

Download
Trajan Press Release - International Media [PDF]
Trajan Press Release - Australian Media [PDF]

More information
Trajan Accelerator

Media contact information
media@trajanscimed.com
+61 (0) 3 9837 4200

PR Consultancy: LBPR
lisa@lbpr.com.au
+61 (0) 429 976 718




Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.
Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Read More

Trajan collaborates with Monash University for the development of HDX training centre
Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region.

Read More

Baker Institute research leads to simple tests for heart and diabetes disease
Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.

Read More